Song Sang-Heon, Yun Young-Pil, Kim Hak-Jun, Park Kyeongsoon, Kim Sung Eun, Song Hae-Ryong
Department of Orthopedic Surgery, Myongji Hospital, 55 Hwasu-ro 14 Beon-gil, Deokyang-gu, Goyang 412-826, Republic of Korea.
Department of Orthopedic Surgery and Rare Diseases Institute, Korea University Medical College, Guro Hospital, No. 80, Guro-dong, Guro-gu, Seoul 152-703, Republic of Korea.
Biomed Res Int. 2014;2014:230152. doi: 10.1155/2014/230152. Epub 2014 Apr 6.
The objective of this study was to assess whether carboxymethyl cellulose- (CMC-) based hydrogel containing BioC (biphasic calcium phosphate (BCP); tricalcium phosphate (TCP) : hydroxyapatite (Hap) = 70 : 30) and bone morphogenic protein-2 (BMP-2) led to greater bone formation than CMC-based hydrogel containing BioC without BMP-2. In order to demonstrate bone formation at 4 and 8 weeks, plain radiographs, microcomputed tomography (micro-CT) evaluation, and histological studies were performed after implantation of all hybrid materials on an 8 mm defect of the right tibia in rats. The plain radiographs and micro-CT analyses revealed that CMC/BioC/BMP-2 (0.5 mg) led to much greater mineralization at 4 and 8 weeks than did CMC/BioC or CMC/Bio/BMP-2 (0.1 mg). Likewise, bone formation and bone remodeling studies revealed that CMC/BioC/BMP-2 (0.5 mg) led to a significantly greater amount of bone formation and bone remodeling at 4 and 8 weeks than did CMC/BioC or CMC/BioC/BMP-2 (0.1 mg). Histological studies revealed that mineralized bone tissue was present around the whole circumference of the defect site with CMC/BioC/BMP-2 (0.5 mg) but not with CMC/BioC or CMC/BioC/BMP-2 (0.1 mg) at 4 and 8 weeks. These results suggest that CMC/BioC/BMP-2 hybrid materials induced greater bone formation than CMC/BioC hybrid materials. Thus, CMC/BioC/BMP-2 hybrid materials may be used as an injectable substrate to regenerate bone defects.
本研究的目的是评估含有BioC(双相磷酸钙(BCP);磷酸三钙(TCP):羟基磷灰石(Hap)=70:30)和骨形态发生蛋白-2(BMP-2)的羧甲基纤维素(CMC)基水凝胶是否比不含BMP-2的含BioC的CMC基水凝胶导致更多的骨形成。为了证明在4周和8周时的骨形成情况,在大鼠右胫骨8毫米缺损处植入所有混合材料后,进行了X线平片、显微计算机断层扫描(micro-CT)评估和组织学研究。X线平片和micro-CT分析显示,在4周和8周时,CMC/BioC/BMP-2(0.5毫克)比CMC/BioC或CMC/Bio/BMP-2(0.1毫克)导致更多的矿化。同样,骨形成和骨重塑研究显示,在4周和8周时,CMC/BioC/BMP-2(0.5毫克)比CMC/BioC或CMC/BioC/BMP-2(0.1毫克)导致显著更多的骨形成和骨重塑。组织学研究显示,在4周和8周时,CMC/BioC/BMP-2(0.5毫克)在缺损部位的整个周边周围存在矿化骨组织,而CMC/BioC或CMC/BioC/BMP-2(0.1毫克)则没有。这些结果表明,CMC/BioC/BMP-2混合材料比CMC/BioC混合材料诱导更多的骨形成。因此,CMC/BioC/BMP-2混合材料可作为可注射基质用于骨缺损的再生。